Grace Therapeutics, Inc. Disposal Group, Including Discontinued Operation, Assets, Current
Grace Therapeutics, Inc. (GRCE) had Disposal Group, Including Discontinued Operation, Assets, Current of $0 as of 2023-03-31, per its 10-K filed 2023-06-23.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent · last filed 2023-06-23
- 2023-03-31: Disposal Group, Including Discontinued Operation, Assets, Current $0.00.
- 2022-12-31: Disposal Group, Including Discontinued Operation, Assets, Current $352.00K.
- 2022-09-30: Disposal Group, Including Discontinued Operation, Assets, Current $352.00K.
- 2022-06-30: Disposal Group, Including Discontinued Operation, Assets, Current $352.00K.
| Period end | Disposal Group, Including Discontinued Operation, Assets, Current | Disposal Group, Including Discontinued Operation, Assets, Current as first filed |
|---|---|---|
| 2023-03-31 | $0.00 10-K · filed 2023-06-23 | |
| 2022-12-31 | $352.00K 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $352.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $352.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $352.00K 10-K · filed 2023-06-23 | $602.00K 10-K · filed 2022-06-21 |
| 2021-12-31 | $587.00K 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $764.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $778.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $768.00K 10-K · filed 2022-06-21 | |
| 2020-12-31 | $1.09M 10-Q · filed 2021-02-09 | |
| 2020-09-30 | $1.05M 10-Q · filed 2020-11-16 | |
| 2020-03-31 | $2.58M 10-K · filed 2021-06-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |